Best GLP-1 Receptor Agonists Newsletters in 2026
NewsletterFIT tracks 3 newsletters that cover GLP-1 receptor agonists as a primary topic, all with posts in the last 90 days. By publicly shown subscriber count, the largest are GLP1 Guide (7K).
Updated Nov 15, 2026 · sorted by publicly shown subscribers · methodology
- 1GLP1 Guide7K subscribers
SubstackWeekly · last post 12 days ago
The latest research and information on GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, Zepbound , etc) and their effects on type 2 diabetes, weight loss, and heart disease.
Likely audience: Pharmacists
- 2
SubstackEvery two weeks · last post 9 days ago
*The intelligence of aging well—with a little rebellion.* Biology. Beauty. Longevity. Research. Reinvention. Style. The tools I'm using, the science I'm decoding, and the conversations women in midlife aren't having…
Likely audience: health-conscious adults over 40
- 3
LinkedInEvery two weeks · last post 17 days ago
Because science isn
Likely audience: Corporate wellness managers
Latest posts from these newsletters
- You're Not…Peptide Queen
- 📅 Last…GLP1 Guide
- Why Stroke…Understanding the science
- 📅 Last…GLP1 Guide
- Why Antibiotics…Understanding the science
- The Supermodel…Peptide Queen
- The Painkiller…Understanding the science
- 📅 Last…GLP1 Guide